hypertension and vitamin D deficiency. Secondary hypertension
Conditions
Interventions
Intervention 1: Patients in group A vitamin D at a dose of 1000 mg daily for 8 weeks. Intervention 2: Intervention group: To group B, vitamin D with a dose of 50,000 mg per week for 8 weeks.
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: serum level vitamin D between 10-30 ng/dl having hypertension stage 1
Exclusion criteria
Exclusion criteria: CKD> 1.2 mg / dL Liver failure patients Proteinuria greater than 500 mg in 24 hours Patients with heart failure Pregnancy Secondary hypertension No consumption more than 20% of the drug delivered to them
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypertension. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: 24-hour blood pressure monitoring and measurement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of vitamin d. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Through a laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Eisa Rezaei
Ahvaz University of Medical Sciences
Outcome results
None listed